ARBE trades 204.6% below Wall Street's consensus target of $2.00.
Last 12 months price action with 12-month analyst target path
The base valuation assumes ARBE achieves its forward estimates and maintains a stable P/E multiple of historical averagesx. This scenario reflects the blended consensus of 2 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of June 28, 2026, Arbe Robotics Ltd. (ARBE) has a Wall Street consensus price target of $2.00, based on estimates from 2 covering analysts. With the stock currently trading at $0.66, this represents a potential upside of +204.6%. The company has a market capitalization of $81M.
Analyst price targets range from a low of $2.00 to a high of $2.00, representing a 0% spread in expectations. The median target of $2.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 1 analysts rating the stock as a Buy or Strong Buy,1 rating it Hold, and 0 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, ARBE trades at a trailing P/E of -1.6x. Analysts expect EPS to grow +21.2% over the next year.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
INVZInnoviz Technologies Ltd. | $127M | $0.57 | $6.00 | +949.7% | Buy | — | 5 |
AEVAAeva Technologies, Inc. | $1.3B | $20.89 | $8.74 | -58.2% | Buy | — | 8 |
OUSTOuster, Inc. | $2.7B | $42.02 | $56.00 | +33.3% | Hold | — | 9 |
LIDRAEye, Inc. | $61M | $1.31 | $12.00 | +816.0% | Hold | — | 4 |
MVISMicroVision, Inc. | $96M | $0.29 | $5.00 | +1618.2% | Buy | — | 8 |
LAZRLuminar Technologies, Inc. | $112M | $0.19 | $86.00 | +45547.6% | Buy | — | 15 |
MBLYMobileye Global Inc. | $6.4B | $7.81 | $13.32 | +70.6% | Buy | 28.2x | 26 |
APTVAptiv PLC | $12.8B | $60.32 | $88.63 | +46.9% | Buy | 9.8x | 33 |
NXPINXP Semiconductors N.V. | $69.9B | $277.02 | $242.60 | -12.4% | Buy | 18.8x | 46 |
TXNTexas Instruments Incorporated | $259.9B | $285.43 | $275.17 | -3.6% | Buy | 37.0x | 65 |
Quick answers to the most common questions about buying ARBE stock.
The consensus Wall Street price target for ARBE is $2, representing 204.6% upside from the current price of $0.6565. With 2 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.
ARBE has a consensus rating of "Buy" based on 2 Wall Street analysts. The rating breakdown is mixed, with 1 Hold ratings making up the largest segment. The consensus 12-month price target of $2 implies 204.6% upside from current levels.
ARBE's current price is $0.6565 with a consensus target of $2 (204.6% implied move). Analyst estimates suggest the stock is undervalued at current levels.
The most bullish Wall Street analyst has a price target of $2 for ARBE, while the most conservative target is $2. The consensus of $2 represents the median expectation. These targets typically reflect 12-month expectations.
ARBE is lightly followed, with 2 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 1 have Buy ratings, 1 recommend Hold, and 0 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month ARBE stock forecast based on 2 Wall Street analysts shows a consensus price target of $2, with estimates ranging from $2 (bear case) to $2 (bull case). The median consensus rating is "Buy".
Wall Street analysts are very optimistic on ARBE, with a "Buy" consensus rating and $2 price target (204.6% upside). 1 of 2 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
ARBE analyst price targets range from $2 to $2, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $2 consensus represents the middle ground.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.